Professor Dr. Rolf W. HARTMANN

Pharmaceutical and Medicinal Chemistry, Saarland University and Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Department Drug Design and Optimization (DDOP) D-66123 Saarbrücken – Campus C23 Phone: +49 681/302-70300 – Fax: +49 681/302-70308 E-Mail: [email protected] www.PharmMedChem.de

Date of Birth 04.05.1952 Place of Birth Mannheim Marital Status married

Education 1972 High school diploma (Abitur with excellence) 1972 - 1976 Undergraduate and graduate studies in: Chemistry, Technical University of Munich and Pharmaceutical Sciences, University of Munich 1977 - 1981 PhD in Pharmaceutical Chemistry (summa cum laude) supervision with Professor Schönenberger, University of Regensburg Scientific Career 1982 - 1983 Postdoc with Professor Jungblut, Max-Planck-Institute for Experimental Endocrinology, Hannover 1984 - 1991 Member of Collaborative Research Center 234 (SFB234) “Experimental Cancer Chemotherapy. Drug synthesis and evaluation on hormone dependent tumours” 1987 Habilitation in Pharmaceutical Chemistry, University of Regensburg 1988 Appointment as Privatdozent (lecturer) 1988 C3-Professorship (associate) for Pharmaceutical Chemistry, Free University, Berlin 1989 C4-Professorship (full) for Pharmaceutical Chemistry, Saarland University, Saarbrücken 1987 and 1990 Research position offers from Pharmaceutical Companies (not accepted) 1996 Professorship for Pharmaceutical Chemistry, University of Bonn (not accepted) 2001 Professorship for Pharmaceutical Chemistry, University of Freiburg (not accepted) 2003 - 2007 Vice President of Saarland University, responsible for Research and Transfer of Technology, 2006 – 2007 also Deputy President 2009 Foundation of the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) and appointment as Department Head

Honors and Awards 1982 Friedrich-Georg-Zimmermann Award for Cancer Resarch 1999 Phoenix-Research Award

Miscellaneous since 1990 Member of Editorial Boards of J. Med. Chem., J. Steroid Biochem. Med. Biol., J. Enz. Inhib. Med. Chem., Heterocycl. Comm., etc. since 1990 Referee of several national and international funding organizations 1995-2004 Editor-in-Chief of Archiv der Pharmazie 1996 - 2004 Elected Referee for the Deutsche Forschungsgemeinschaft (DFG) since 2010 Member of Editorial Advisory Board of Current Enzyme Inhibition

Spin Offs 2000 Foundation of Pharmacelsus GmbH, Saarbrücken 2005 Foundation of ElexoPharm GmbH, Saarbrücken 2010 Foundation of PharmBioTec GmbH, Saarbrücken

Patents In the last ten years 15 patent families applications have been filed and patents have been granted. Two of which have been subject of a licensing and collaboration contact between UdS/ElexoPharm and Merck/MSD, which is focused on the ASI inhibitors developed by the Hartmann group.